Sign In

Marciela D.

Vaccine and Monoclonal Development | Influenza & Emerging Viral Diseases | Pandemic Preparedness | Virology | Systems Biology

Marciela D. is an accomplished virologist with a strong dedication to enhancing pandemic readiness through innovative leadership and cooperative scientific endeavors.

With a background in Virology from Harvard University and degrees in Biological Sciences and Hispanic Studies from Carnegie Mellon University, Marciela brings a wealth of academic knowledge to her work.

During her tenure at the National Institute of Allergy and Infectious Diseases (NIAID), Marciela initiated the SARS-CoV-2 Assessment of Viral Evolution (SAVE) program, which focuses on investigating how virus variants impact COVID-19 treatments and vaccines.

She currently manages various interdisciplinary teams working on the development of medical countermeasures for influenza and COVID-19, demonstrating her exceptional skills in team leadership and collaboration.

Marciela has a proven track record of establishing strategic alliances among academic, governmental, and industrial sectors to propel translational research and the advancement of medical countermeasures.

Her prior roles include serving as an Interdisciplinary Scientist at the Biomedical Advanced Research and Development Authority, as well as holding positions at the FDA, Broad Institute, and University of Pennsylvania, showcasing her diverse and extensive professional background in the field of virology.

With her profound expertise and experience, Marciela D. continues to play a pivotal role in the field of infectious diseases and pandemic response.

Marciela D.
Add to my network

Location

Bethesda, Maryland, United States